1. Home
  2. RNW vs LQDA Comparison

RNW vs LQDA Comparison

Compare RNW & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ReNew Energy Global plc

RNW

ReNew Energy Global plc

HOLD

Current Price

$7.58

Market Cap

2.7B

Sector

Utilities

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$30.73

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNW
LQDA
Founded
2011
2004
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.5B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
RNW
LQDA
Price
$7.58
$30.73
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
$7.83
$37.40
AVG Volume (30 Days)
1.1M
2.2M
Earning Date
11-10-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
413.66
N/A
EPS
0.26
N/A
Revenue
$1,382,164,625.00
$69,216,000.00
Revenue This Year
N/A
$424.31
Revenue Next Year
$16.58
$359.32
P/E Ratio
$29.00
N/A
Revenue Growth
46.76
343.41
52 Week Low
$5.42
$10.37
52 Week High
$8.24
$32.80

Technical Indicators

Market Signals
Indicator
RNW
LQDA
Relative Strength Index (RSI) 52.62 60.95
Support Level $7.22 $27.76
Resistance Level $7.69 $32.80
Average True Range (ATR) 0.11 1.78
MACD 0.03 0.20
Stochastic Oscillator 77.66 68.59

Price Performance

Historical Comparison
RNW
LQDA

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: